Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shi-Yan Qian"'
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Purpose This study aimed to comprehensively assess the safety of rimegepant administration in real-world clinical settings. Methods Data from the Food and Drug Administration Adverse Event Reporting System (FAERS) spanning the second quarter
Externí odkaz:
https://doaj.org/article/dc2843a819734fbab27e00948d92e23f
Autor:
Jing-Ying Wu, Jiang-Li Yang, Jia-Ling Hu, Shan Xu, Xiao-Jie Zhang, Shi-Yan Qian, Min-Li Chen, Mahad Abdulkadir Ali, Juan Zhang, Zheng Zha, Guo-Qing Zheng
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMultiple sclerosis (MS) is the most common non-traumatic disabling disease affecting young adults. A definitive curative treatment is currently unavailable. Many randomized controlled trials (RCTs) have reported the efficacy of Chinese herb
Externí odkaz:
https://doaj.org/article/95f5f4acfb44429d8908ccb6463f8119
Autor:
Xiao-Jie Zhang, Yi-Jing Wang, Xiao Lu, Peng-Jie Ying, Shi-Yan Qian, Jie Liang, Guo-Qing Zheng
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Background: HuatuoZaizao pill (HZP), a Chinese patent medicine, is often used in the treatment of stroke. However, there is still a lack of enough evidence to recommend the routine use of HZP for stroke. This study is aimed at evaluating the quality
Externí odkaz:
https://doaj.org/article/b19ce1492e3247469286680a043613d0